ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 180973 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 180973; 2) Community: the network communities that were significantly associated with the response to NSC 180973; 3) Molecule: the relationships between components within communities and NSC 180973; 4) MDR: the compounds that were significantly associated with the NSC 180973.

NSC Compound Enrichment Correlation
NSC 646604 Null 0.000864859564133839 0.23716572
NSC 671888 Null 0.000864859564133839 0.42804216
NSC 673791 Null 0.000864859564133839 0.28511189
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.000864859564133839 0.45774298
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.000864859564133839 -0.46954923
NSC 756193 GSK978744A 0.00098268217727352 0.32491305
NSC 7801 Aniline violet (component of) 0.00098268217727352 0.16655426
NSC 637578 N-[3-(2-Pyridyl)isoquinolin-1-yl]-2-pyridinecarboxamidine 0.00119931827492064 0.11653083
NSC 696864 Null 0.00119931827492064 0.44205946
NSC 626307 Austrocortirubin 0.00126952303154152 0.40757303
Total:107  Current:4    [First] [Prev] [Next] [Last]